Abrdn 생명 과학 투자자
US ˙ NYSE ˙ US87911K1007

SecurityHQL / Abrdn Life Sciences Investors
InstitutionCommonwealth Equity Services, Llc
Latest Disclosed Ownership25,626 shares
Latest Disclosed Value $ 430,006
Commonwealth Equity Services, Llc reports 22.33% decrease in ownership of HQL / Abrdn Life Sciences Investors

On February 12, 2026 - Commonwealth Equity Services, Llc filed a 13F-HR form disclosing ownership of 25,626 shares of Abrdn Life Sciences Investors (US:HQL) valued at $430,004 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 22, 2025 disclosing 32,995 shares of Abrdn Life Sciences Investors. The current value of the position is $433,592 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-12 2025-12-31 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 25,626 -7,369 -22.33 430
2025-10-22 2025-09-30 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 32,995 -172 -0.52 1 0.0007
2025-08-06 2025-06-30 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 33,167 4,045 13.89 0 0.0006
2025-05-09 2025-03-31 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 29,122 -997 -3.31 0 0.0005
2025-02-10 2024-12-31 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 30,119 933 3.20 0 0.0006
2024-10-18 2024-09-30 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 29,186 -4,602 -13.62 0 0.0007
2024-07-31 2024-06-30 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 33,788 868 2.64 0 0.0008
2024-04-29 2024-03-31 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 32,920 -87 -0.26 0 0.0007
2024-02-06 2023-12-31 13F ABRDN LIFE SCIENCES INVESTOR SH BEN INT 87911K100 33,007 -5,866 -15.09 0 0.0008
2023-10-23 2023-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 38,873 -6,315 -13.97 0 0.0010
2023-08-10 2023-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 45,188 -14,651 -24.48 1 0.0012
2023-05-11 2023-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 59,839 -1,192 -1.95 1 0.0017
2023-02-07 2022-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 61,031 1,354 2.27 1 -100.00 0.0021
2022-11-14 2022-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 59,677 -1,330 -2.18 815 -6.11 0.0021
2022-07-19 2022-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 61,007 -2,838 -4.45 868 -17.80 0.0023
2022-05-04 2022-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 63,845 12,292 23.84 1,056 6.56 0.0024
2022-01-31 2021-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 51,553 4,847 10.38 991 2.06 0.0022
2021-10-29 2021-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 46,706 7,432 18.92 971 15.32 0.0024
2021-08-11 2021-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 39,274 -2,394 -5.75 842 2.56 0.0021
2021-05-04 2021-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 41,668 8,231 24.62 821 24.39 0.0023
2021-02-11 2020-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 33,437 3,039 10.00 660 23.60 0.0020
2020-11-05 2020-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 30,398 -3,104 -9.27 534 -11.15 0.0018
2020-08-12 2020-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 33,502 -1,173 -3.38 601 15.80 0.0023
2020-05-11 2020-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 34,675 -3,438 -9.02 519 -21.84 0.0024
2020-02-05 2019-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 38,113 40 0.11 664 15.68 0.0025
2019-10-30 2019-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 38,073 13,053 52.17 574 36.34 0.0024
2019-07-19 2019-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 25,020 -1,584 -5.95 421 -7.47 0.0019
2019-05-13 2019-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 26,604 -1,602 -5.68 455 6.81 0.0021
2019-02-11 2018-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 28,206 -10,253 -26.66 426 -45.73 0.0023
2018-11-06 2018-09-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 38,459 -3,531 -8.41 785 -0.51 0.0038
2018-07-31 2018-06-30 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 41,990 2,748 7.00 789 4.64 0.0041
2018-05-14 2018-03-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 39,242 320 0.82 754 -1.31 0.0041
2018-02-12 2017-12-31 13F TEKLA LIFE SCIENCES INVS SH BEN INT 87911K100 38,922 38,922 764 0.0042
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.